MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Clinical trial NCT05739136 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05739136
Sponsor: Sumitomo Pharma Switzerland GmbH
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Pregnancy Related Pregnancy Complications Pregnancy, High Risk

Start date: 2025-04-30
Primary completion: 2027-05-01
Enrollment: 530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.